<DOC>
	<DOCNO>NCT01368406</DOCNO>
	<brief_summary>The aim study evaluate efficacy intervention weight gain management patient schizophrenia spectrum compare treatment usual ( TAU ) , evaluate effect program metabolic profile , symptom quality life .</brief_summary>
	<brief_title>Lifestyle Intervention Weight Gain Management Patients With Schizophrenia</brief_title>
	<detailed_description>The study take place four institution : Schizophrenia Program ( PROESQ- Universidade Federal de São Paulo ) , Schizophrenia Program Institute Psychiatry PROJESQ ( Universidade de São Paulo ) , CAISM ( Centro de Atenção Integrada à Saúde Mental ) Irmandade Santa Casa de Misericórdia de São Paulo , CAPS Luiz da Rocha Cerqueira , city São Paulo . Participants randomly assign intervention group standard care group use table randomization web site www.randomization.com . The patient ' weight record monthly . All patient weigh morning , scale , without shoe , individual wear light clothes . Waist consider level navel . Measures collect investigator assessment . Body mass index ( BMI ) calculate weight kilogram divide square height meter . The investigator record sociodemographic data , clinical data physical exam ( weight , height , BMI , waist circumference blood pressure ) . Patients diagnose schizophrenia SCID-P ( REF ) . Severity disease assess use PANSS , Calgary Depression Scale , CGI-S CGI-I . GAF , ILSS-BR , follow self-rated scale : WHOQoL-BREF , Rosenberg self-esteem scale , IPAQ , DINE Fagerstrom use evaluate functionality ( GAF ) , independent living skill ( ILSS-BR ) , quality life ( WHOQoL-BREF ) , self esteem ( Rosenberg self-esteem scale ) , physical activity ( IPAQ- short version ) , fat fiber ingestion ( DINE ) , smoke ( Fagerstrom ) . Raters keep blind patient 's treatment condition . Fasting glucose , total cholesterol , HDL , LDL , triglyceride , insulin , HOMA-IR index assess baseline , 3 month .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Weight Gain</mesh_term>
	<criteria>Eligible patient 18 65 year age , antipsychotic medication , asymptomatic ( PANSS ≤ 60 ) , outpatient status DSMIV diagnosis schizophrenia , schizoaffective disorder psychosis , present interest theme program . history diabetes mellitus , eat disorder ( anorexia bulimia ) , drug alcohol abuse , acute psychotic state need intensive management . There use medication weight control subject intervention followup period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>weight gain</keyword>
	<keyword>intervention</keyword>
</DOC>